IBFAR2
- 1 lab in 1 country
- Funder: National Natural Science Foundation of China
- Animals1
Outcomes
1CD8+ T cell antitumor activity
upin mice1
1 study
CD8+ T cell antitumor activity
upin mice1
IBFAR2 improves CD8+ T cell antitumor activity in mice.
“treatment with our developed BFAR inhibitor, iBFAR2, rescued the antitumor activity of aged CD8+ T cells by restoring TRM generation”
Animalsmouse tumor modelsCD8+ T cells
Age-related decline in CD8⁺ tissue resident memory T cells compromises antitumor immunity
Nature aging26 Nov 2024
Latest
Nature Aging
Age-related decline in CD8⁺ tissue resident memory T cells compromises antitumor immunity
Experiments in miceBlood and immune system